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In this review we briefly discuss animal experiments involving acute traumatic spinal cord injury (SCI) and the need for larger 
animals in testing experimental therapies. This literature overview, including the discussion of our own results from animal 
models, examines the use of hypothermia as a treatment method for SCI. Finally, we report the results of hypothermia application 
in clinical trials. Minipigs have been proposed as a potentially preferable model to rodents (typically rats) for predicting outcomes 
in human SCI due to their closer anatomical similarity to humans. In various animal studies, hypothermic treatment applied in the 
acute phase after SCI has resulted in neuroprotective effects, most likely due to inhibition of blood flow and oxygen consumption 
and reduction of overall metabolic activity and inflammation, resulting in improved nerve tissue sparing. Small‑scale human 
clinical trials have been carried out, involving general (whole‑body, systemic) or local hypothermia (close to the SCI site), with 
encouraging results. Nevertheless, further multi‑center, randomized, double‑blind studies with much larger patient numbers are 
necessary so that protocols can be standardized in order for hypothermia treatment to be reliably applied in clinical practice.
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INTRODUCTION
Traumatic spinal cord injury (SCI) is a life‑threaten‑
ing neurological condition resulting in partial or com‑
plete loss of motor, sensory and autonomic innervation 
below the injury level. The consequences of SCI include 
not only a decreased quality of life for the injured but 
also an adverse socio‑economic impact on their rela‑
tives and society as whole (Piatt et al., 2016; Nori et al., 
2017). Despite recent progress in the understanding 
of SCI pathophysiology and progress in experimental 
therapy, the results of clinical treatment strategies re‑
main unsatisfactory (Ahuja et al., 2017). Current sur‑
gical practices allow for safe decompression and sub‑
sequent stabilization, which primarily benefits the 
surrounding structures and only slightly affects the 
secondary pathophysiology of the SCI itself (Ahuja et 
al., 2017; Rath and Balain, 2017). Additional pharma‑
cological treatment primarily focuses on one or two 
mechanisms of spinal pathology, and thus it currently 
results in only minimal functional improvement. Other 
neuroprotective strategies such as therapeutic hypo‑
thermia alone or in combination with other interven‑
tions, whose mechanisms of action are multifactorial 
and may thereby protect nervous tissue and minimize 
overall loss of neurological function, are therefore be‑
ing considered for experimental and clinical trials.
Experimental animals used in SCI studies
Although detailed descriptions of the causes and 
symptoms of traumatic SCI date back to ancient Egyp‑
tian times, intensive research into the pathological pro‑
Received 12 April 2019, accepted 11 March 2020
REVIEW
Acta Neurobiol Exp 2020, 80: 172–178
DOI: 10.21307/ane-2020-016
brought to you by COREView metadata, citation and similar papers at core.ac.uk
provided by Exeley Inc.
Hypothermia in traumatic spinal cord injury 173Acta Neurobiol Exp 2020, 80: 172–178
cesses of SCI using experimental animals began only in 
the second half of last century. Initially, dogs, cats and 
monkeys were used (Bigelow and McBirnie, 1953). In 
these studies, spinal injury models varied and produced 
differing severities of injury. Furthermore, non‑stan‑
dardized histological, electrophysiological methods and 
functional measurements were used. Inconsistencies in 
experimental animal behavior assessment scales due to 
interspecies anatomical differences (dogs, cats, non‑hu‑
man primates) often resulted in contradictory findings. 
This led to the standardization of experimental proce‑
dures and the use of laboratory rodents. Rats have be‑
come the most commonly used laboratory animals due to 
several similarities with humans in the pathophysiology 
and recovery processes experienced after traumatic SCI 
(Rosenzweig and McDonald, 2004). Despite the indisput‑
able benefits of rat experiments, there are certain lim‑
its that have to be considered before translating results 
from rodents into human practice. Thus, in many cases 
the promising treatment documented in rats failed when 
applied to humans (Rosenzweig and McDonald, 2004).
These findings suggest that the experimental therapy 
found to be beneficial in rats suffering from SCI should 
be tested on larger animals, such as minipigs and pigs, 
prior to introduction into human treatment (Kwon et al., 
2015). Because the anatomical parameters of pig organs 
correlate with those in humans, they provide a more 
relevant platform for pharmacotherapy, biomaterial in‑
ventions, electrophysiological and rehabilitation studies 
(Bassols et al., 2014). Pigs are considered to be one of 
the most suitable animal species used in translational 
medical research. They share similar anatomical and 
physiological characteristics with humans, particularly 
the cardiovascular, urinary, reproductive and digestive 
systems (Bassols et al., 2014). In the pig spinal cord, the 
localization of the corticospinal tract (CST) inside the 
lateral columns of the white matter is more similar to 
humans than to rodents (Leonard et al., 2017). In terms 
of anatomical function, the CST plays a key role in lo‑
comotion of the pigs’ hindlimbs. This is in contrast to 
rodents, where the rubrospinal tract is predominantly 
involved. These anatomical and functional similarities 
to humans provide support for pigs as a reliable animal 
model for preclinical research into traumatic SCI (Leon‑
ard et al., 2017). In general, it should be noted that both 
small and large animal models of SCI have limitations in 
their ability to predict outcomes in human SCI (Rosenz‑
weig and McDonald, 2004; Bassols et al., 2014).
Spinal cord injury pathology 
Extensive research based on animal models has aid‑
ed in the clarification of complex nervous tissue pro‑
cesses that occur in the spinal cord after injury. The 
pathophysiological process induced by tissue damage 
is divided into two phases – the primary injury and the 
secondary injury. Primary injuries arise from mechani‑
cal disruption caused by compression, contusion, tran‑
section or distraction/stretching of the spinal column 
(Rosenzweig and McDonald, 2004; Ramer et al., 2005; 
Wang and Pearse, 2015). This injury usually occurs with 
vertebral bone fracture and/or dislocation of the spine. 
However, spinal epidural hematomas or abscesses may 
cause spinal cord compression and injury as well. With‑
in minutes of the mechanical insult, the secondary 
mechanisms of SCI begin, accompanied by subsequent 
pathophysiological and molecular changes that am‑
plify the injury and enlarge the lesion site. Currently, 
there are several well‑explored secondary mechanisms 
of SCI (Ramer et al., 2005), negatively affecting not only 
the cells that survive the primary damage but also the 
surrounding nerve tissue, thus extending the primary 
damage (Ramer et al., 2005) (Table I). Subsequent find‑
ings and an increased understanding of these process‑
es provided opportunities to actively intervene during 
their course of development in order to minimize their 
unfavorable progress (Ramer et al., 2005). The purpose 
of neuroprotective treatment is to reduce the second‑
ary damage that typically follows a primary insult and 
increases its extent (Ahmad et al., 2014).
Hypothermia-induced neuroprotection
Hypothermia has been used for therapeutic purpos‑
es for hundreds of years. Application of snow and ice to 
wounded areas of the body was recommended by Hip‑
pocrates (Chang et al., 2007). However, in 1700 the Scot‑
tish physician James Currie was the first to successfully 
use whole‑body cooling for the treatment of various 
clinical disorders, and he documented the range of hu‑
man body temperatures in health, disease and exper‑
imental conditions (Karnatovskaia et al., 2014). Since 
1953, when Bigelow detected the positive effect of hy‑
pothermia on the brain during heart surgery, the sys‑
tematic study of its neuroprotective effect on nerve tis‑
sue has advanced (Bigelow and McBirnie, 1953).
Hypothermia‑mediated neuroprotection has been 
reported for all phases of nerve tissue damage, but the 
greatest beneficial effects have been observed during 
the first stages of injury (Table I). In acute SCI (within 
48 h of injury), hypothermia reduces blood flow, oxygen 
consumption and total metabolic activity in the tissue, 
oxidative stress and the formation of free radicals are 
reduced and inhibition of lactate formation prevents 
the development of acidosis. These factors lead to de‑
creased edema formation. Concomitantly, with the re‑
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duction in blood supply to the traumatized neuronal 
tissue, there is also reduced lymphatic drainage. On 
the other hand, the decreasing lymph flow caused by 
hypothermia subsequently results in the accumulation 
of metabolic waste, which needs to be removed during 
the following rewarming period (Chen and Chien, 1977; 
Topuz et al., 2010). In the subacute phase (up to 2 weeks 
after injury), hypothermia induces an inhibitory effect 
on the inflammatory process, as well as protecting the 
blood‑brain barrier (Karnatovskaia et al., 2014) (Table I). 
During deep cooling, i.e. below 25°C, the most com‑
monly observed effect was on oxygen consumption, 
while during less intense cooling the secondary chang‑
es in the damaged tissue were predominantly affected 
(Strauch et al., 2004; Yoshitake et al., 2007; Dietrich et 
al., 2011).
General hypothermia
General (systemic) hypothermia can be induced by 
physical and pharmacological means. Methods for in‑
ducing physical hypothermia include a cooling blanket 
or vest, ice pad or infusion of rapidly‑cooled saline (Ike‑
da et al., 2012) (Table II). Pharmacological hypothermia 
is related to several classes of drugs: cannabinoids, opi‑
oid receptor activators, transient receptor potential 
vanilloid, neurotensins, thyroxine derivatives, dopa‑
mine receptor activators, hypothermia‑inducing gases 
and others (Table II). However, both the neuroprotec‑
tive action and side effects of each must be considered 
(Zhang et al., 2013). 
Most SCI experiments have been performed at the 
level of the thoracic and lumbar segments of the spi‑
nal cord, while the number of experiments conducted 
in the cervical area in rats is significantly lower (Jou, 
2000; Strain and Waldrop, 2005; Lo et al., 2009). The pro‑
cess of cooling is primarily carried out at 30‑34°C body 
temperature, lasting from 20 min to 4 h or until the end 
point of the experiment. Hypothermia is induced im‑
mediately or up to 15‑30 min after induction of SCI (Yu 
et al., 2000; Westergren et al., 2001). Maybhate and col‑
leagues (2012) applied modest systemic hypothermia of 
32 ± 0.5°C lasting for 2 h after thoracic SCI in rats.
 Their results revealed significant improvement in 
electrophysiological, functional neurological and his‑
tological findings. 
Our study also demonstrated beneficial effects of 
systemic hypothermia. Rats underwent SCI at the tho‑
racic level (Th8‑Th9), followed by application of ice 
pads, which induced systemic hypothermia at 32°C with 
gradual rewarming to 37°C and resulted in improved 
locomotion as well as bowel functions (Grulova et al., 
2013). Significant bladder function improvement was 









≤ 2 hours blood‑brain barrier damage; vasospasm; decreased blood 
flow; hemorrhage; edema; ischemia; spinal shock; microglia 
activation; neuronal death
‑  surgical decompression: relieving 
mechanical pressure on the vascular 
circulation, reducing hypoxia and 
ischemia 
‑  spinal cord stabilization 
‑  neuroprotection mediated  
by glucocorticoid application
Secondary
≤ 48 hours Acute microglia activation; neutrophil infiltration;  
release of pro‑inflammatory cytokines: IL‑1β, TNFα, IL‑6;
chemokines: CXCL1, CXCL12;
oxidative stress: increased ROS production NO, iNOS; lipid 
peroxidation; glutamate excitotoxicity; ionic imbalance; 
mitochondrial damage; apoptosis of neurons and 
oligodendroglia; demyelination; blood‑brain barrier damage; 
neuronal cell death; axonal swelling; hypotension; hypoxia
‑  neuroprotection mediated by 
combined hypothermia and 
glucocorticoid application
‑  immuno‑modulation
‑  remyelination mediated by delivery  
of oligodendroglial cells
≤ 14 days Subacute infiltration of monocytes, macrophages, microglia; reactive 
astrocytosis; apoptosis of oligodendrocytes; demyelination; cyst 
and glial scar formation; neuropathic pain; chemokine release; 
phagocytosis; blood‑brain barrier recovery; edema regression
‑  neuroprotection mediated by 
glucocorticoid application
‑  immuno‑modulation
‑  scar degradation 
≤ 6 months Transient glial scar and cysts maturation; apoptosis of oligodendrocytes; 
demyelination; lesion stabilization; release of neurite growth 
inhibitors: Nogo, MAG, ROCK; Wallerian degeneration
‑  rehabilitation: body 
weight‑supported gait training
≥ 6 months Chronic neuro‑reparatory processes; anti‑inflammatory phenotype of 
microglia and macrophages (M2); Wallerian degeneration 
‑  rehabilitation: robotic rehabilitation  
of SCI individual
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recorded after five days, while complete bladder recov‑
ery was observed two weeks after treatment (Grulova et 
al., 2013). This was significantly better compared with 
the experimental group without systemic cooling, in 
which the bladder recovery took as much as 25‑28 days, 
confirming that hypothermia induced neuroprotection 
of bladder function. Furthermore, histological analyses 
revealed enhanced sparing of spinal cord tissue with 
smaller cavities and more preserved white and gray 
matter (Grulova et al., 2013). 
Overall, the most effective systemic hypothermia in 
relation to other organs is when moderate cooling be‑
tween 32‑34°C is induced immediately after the trauma. 
Hypothermia should last up to 48 h, and should be fol‑
lowed by slow rewarming at 0.1°C per h (Martirosyan et 
al., 2017). A recent study has provided evidence that sys‑
temic hypothermia (28°C) can effectively counteract the 
increase in extracellular ascorbate concentration after 
acute SCI. Thus, a significant reduction in spinal cord 
ascorbate concentration in rats following spinal injury 
may be related to neuroprotective mechanisms during 
the secondary phase of injury (Zhang et al., 2019). 
The drawback of systemic hypothermia correlates 
with the reduction in total body temperature, which 
influences all biological processes in the body. Each of 
the therapeutic phases of hypothermia, induction and 
maintenance as well as return to normal body tempera‑
ture, is associated with risks, especially to the cardiore‑
spiratory apparatus (Karnatovskaia et al., 2014). How‑
ever, after additional and more detailed experiments, 
it is expected that the clinical application of general 
hypothermia will gradually increase in the near future.
Local hypothermia
Another cooling procedure uses local hypothermia, 
in which surgical and decompression procedures allow 
the spinal cord surface to be accessible for cooling. The 
principle of local spinal cord hypothermia is to cool the 
nerve tissue near the epicenter of the damage. Sever‑
al local cooling systems have been developed for SCI 
(Bazley et al., 2014). The cooling process is carried out 
either intrathecally or epidurally, in which opening of 
the dura mater (durotomy) would be necessary or not, 
respectively, to cool the spinal cord directly. Transcu‑
taneous cooling is another possible mechanism for de‑
creasing paraspinal temperature that avoids laminec‑
tomy (Demian et al., 1971; Hansebout and Hansebout, 
2014) (Table II). The most frequently utilized technique 
involves heat exchanger tubing being inserted under 
the targeted site of spinal injury (paravertebral mus‑
cle in thoracic segments) and by circulating cold solu‑
tion local hypothermia is achieved (Table II). In several 
studies, a heat exchanger (M‑ or U‑shaped copper tube) 
was subcutaneously inserted above the spinal column 
at the lesion site in the thoracic area (T6‑T8) spinal 
hypothermia and was induced at 30 (0.5)°C for either 
5 or 8 h, followed by gradual rewarming to 37°C. This 
approach improved motor behavior recovery for a long 
period, lasting up to 8 weeks (Teh et al., 2018). In anoth‑
er study, epidural perfusion was used in rats after SCI to 
induce local hypothermia (18°C) for 170 min with grad‑
ual rewarming to 37°C. Several beneficial effects were 
observed in rats subjected to hypothermia: downregu‑
lation of axon regeneration inhibitors (RhoA, ROCK‑II, 
NG2, Neurocan, Brevican, and Nogo‑A), decreased de‑
myelination and enhanced axon regeneration, which 
ultimately resulted in recovery of hindlimb function 
(Xu et al., 2016). After the observation of promising re‑
sults in rats, it was necessary to verify the effects of hy‑
pothermia in larger animal models (Kwon et al., 2015). 
Initially, studies were proposed for the prevention 
of paraplegia associated with thoracoabdominal aneu‑
rysm repair (Coselli et al., 2002). These experiments 
confirmed that epidural cooling provided by a special 
catheter containing cold saline solution circulating in 
an isolated lumen induces a protection effect against 
ischemic SCI in pigs (Mori et al., 2005; Yoshitake et al., 
2007). Based on these encouraging results, further spi‑
nal cord cooling methods have been developed and ver‑
ified in other SCI models.
In our previous experiment, we studied the effects 
of local hypothermia on selected parameters in a mini‑
pig model of contusion SCI using a computerized com‑
pression device. In this model we were able to scale the 
impact strength (8N, 15N, 18N) and thus compare the 
findings for varied degrees of contusion (Gedrova et al., 
2018; Zavodska et al., 2018). In the control (normother‑
mic) group, the graded lesion at the impact site was re‑
corded as 47% loss of tissue with a force of 8N impact, 
67% loss of tissue with a force of 15N impact and 79% 
loss of tissue with a force of 18N impact after 9 weeks of 
survival. Moderate injury impact (8N and 15N) accompa‑
nied by local epidural cooling with 19°C, induced 30 min 
after SCI for 5 h, revealed an increase of 11% in the gray 
mass at the site of injury. Nerve tissue sparing was also 
observed in the white matter, especially in the dorsal 
columns (with 13‑15% sparing). While hypothermia af‑
ter the injury induced by an impact of 8N led to greater 
functional improvement, after the more severe impact 
of an 15N impact it had no beneficial effect on locomo‑
tion. These findings raised the question of the extent to 
which nerve tissue sparing must be present in order to 
achieve a better functional outcome. We therefore sys‑
tematically examined changes in the cranial and cau‑
dal segments (3 cm long) adjacent to the central lesion. 
Local hypothermia after 8N force impact significantly 
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increased the number of fibers and neurofilaments in 
the gray and white mass near the epicenter. The num‑
ber of nerve fibers (axons) in the funiculus lateralis was 
increased in the cranial segment (+1 cm) by 25% and in 
the caudal segment (‑1 cm) by 19%, which correlated 
with faster functional improvement in the hypother‑
mia‑induced group compared to the normothermic con‑
trol. Thus, the preserved integrity of the nerve tissue 
in the cranial as well as the caudal segment adjacent 
to the epicenter with corresponding neurofilaments in 
the lateral columns may be critical for recovering motor 
function. In contrast, local hypothermia after the 18N 
force impact, despite detected neuroprotection in white 
and gray mass of the caudal segment, ultimately did not 
lead to improvement in the final neurological score. It 
is assumed, therefore, that the 18N force is a very strong 
impact causing serious pathophysiological changes 
against which hypothermia is ineffective.
Therapeutic hypothermia used in human  
clinical trials
The positive effects of local and general hypothermia 
in animal experiments following acute traumatic SCI has 
led to clinical trials. Among the first was a clinical tri‑
al of local hypothermia in patients with spinal epidural 
abscess (Jackson and Assam, 1964). Further advances in 
inducing and maintaining hypothermia have enabled 
more accurate evaluations of this form of treatment. 
Demian and colleagues (1971) demonstrated its benefit 
in three patients with acute SCI in a cervical segment, 
without change in their overall body temperature, blood 
flow and respiratory parameters. This led to the launch 
of clinical studies including larger numbers of patients. 
Romodanov and colleagues (1979) performed hypother‑
mia in 113 patients, and they observed its positive effects 
in reducing bleeding and swelling of the spinal cord, di‑
minishing muscle spasticity, improving motor function 
and alleviating pain. Hansebout and Hansebout (2014) 
examined the effect of local hypothermia in a study of 
20 patients after SCI in the cervical and thoracic region. 
After decompression of the spinal canal, which was per‑
formed within 8 h of injury, they cooled the intact dura 
for 4 h until the temperature of the dura was 6°C. They 
observed an improvement in mean motor and sensitiv‑
ity scores. These patients, treated with surgical decom‑
pression, glucocorticoid administration and regional 
hypothermia, experienced better recovery than might 
have been expected with standard treatment proce‑
dures (Hansebout and Hansebout, 2014). Together with 
ongoing local hypothermia testing, clinical trials using 
systemic hypothermia have also been launched. The 
case report of an NFL player in the USA, who suffered 
a C3/4 dislocation fracture causing complete motor pa‑
ralysis and sensory loss (ASIA A grade), has been infor‑
mative in terms of a more systematic study. Timely sys‑
temic hypothermia (33.5°C) was performed for a period 
of 36 h along with surgical decompression and methyl 
prednisone administration. Afterwards, along with re‑
habilitation, rapid neurological improvement and ASIA 
conversion from A to D grade was observed (Cappuccino 
et al., 2010). In another study, Levi and colleagues (2009) 
demonstrated the safety of systemic hypothermia using 
a catheter, which was then endovascularly inserted into 
patients with SCI (Levi et al., 2010). Similarly, Madhavan 
and colleagues (2012) and Dididze and colleagues (2013), 
noticed significant overall improvement after using sys‑
temic intravascular hypothermia (33°C), induced imme‑
diately post‑surgery and maintained for 48 h post‑oper‑
atively. This management paradigm failed to counteract 
deterioration in respiratory complications, with throm‑
Table II. Cooling methods to induce and maintain hypothermia.
General Hypothermia Local Hypothermia
Physical Methods Pharmacological Methods Physical Methods
Surface cooling devices Endovascular cooling Drugs Heat exchanger tubing system
air and water circulating cooling 
blankets; hydrogel‑coated 
water‑circulating pad; ice packs, 
pads; wrapping garments; 
cooling‑vest
intravenous infusion of:  
ice‑cold saline,  
ice‑cold Ringer’s solution
cannabinoids; opioid receptor 
activators; transient receptor 
potential vanilloid; neurotensins; 
dopamine receptor activators; 
adenosine; inhalational 
anesthetics
intrathecal; epidural;  
paraspinal; transcutaneous
Cannabinoids: bind to their specific CB1 receptors distributed in the central nervous system, particularly of preoptic anterior nucleus of the hypothalamus (POAH),  
inducing hypothermic effects. 
Opioids: induce hypothermia via interaction with opioid receptors‑μ, κ, δ. 
Transient receptor potential vanilloid 1: nonselective cation channel that plays a thermoregulatory role through peripheral sensors and the POAH. 
Neurotensins: tridecapeptide neurotransmitter mediating hypothermia by a G protein coupled receptor – NT receptor type 1 (NTS1). 
Dopamine receptor activators: induce hypothermia via D2‑like receptors. 
Adenosine: triggers hypothermia via agonism at A1 and A3 adenosine receptors. 
Inhalational anesthetics: sevoflurane, isoflurane induce hypothermia by inhibiting central thermoregulation.
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boembolic complications occurring in 14.2% of patients 
(Dididze et al., 2013). 
With this in mind, a clinical trial with systemic hy‑
pothermia following acute SCI is currently under way. 
In 2017, the Miami Project to Cure Paralysis initiated 
a larger phase II/III trial of systemic hypothermia in 
acute (≤ 24 h) cervical SCI (ASIA C) patients. In this pro‑
spective multicenter case‑controlled study, patients re‑
ceive modest (33°F) intravascular hypothermia for 48 h 
(Donovan and Kirshblum, 2018). Another clinical trial 
with systemic hypothermia was completed in January 
2019, the first results of which are expected in 2020. 
Nevertheless, the limited number of patients in these 
studies with differently applied hypothermia, time of 
initiation and time of duration does not yet allow for 
its application in clinical practice, and it remains at the 
clinical trial stage. A multi‑center, randomized, dou‑
ble‑blind study with a significantly greater number of 
patients and a clearly defined method, timing and du‑
ration of administration, temperature range and tech‑
nical execution will be required. 
CONCLUSIONS
Hypothermia, as part of acute traumatic SCI treat‑
ment, has shown promising neuroprotective effect in 
experimental and preclinical animal models. However, 
its clinical application is still very limited due to sever‑
al factors. Systemic hypothermia is associated with ad‑
verse effects on other organs, especially the cardiore‑
spiratory apparatus. Local hypothermia is time delayed 
and requires advanced surgical procedure. Large clini‑
cal trials are therefore required for investigation and 
standardization of protocols providing the most ben‑
eficial effect of hypothermia for treating SCI. In par‑
ticular, identification and extension of the therapeutic 
window and determination of the effective duration of 
hypothermia but also optimal warming procedures are 
at the forefront of current medical research. The neu‑
roprotective effect and the availability and affordable 
cost of the combined treatment, which is necessary for 
this type of SCI damage, create significant interest for 
further experimental and, particularly, clinical studies 
in hypothermia.
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